Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
4,667,969
-
Share change
-
+664,587
-
Total reported value
-
$620,446,822
-
Put/Call ratio
-
43%
-
Price per share
-
$132.90
-
Number of holders
-
150
-
Value change
-
+$88,545,487
-
Number of buys
-
83
-
Number of sells
-
46
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2018
As of 31 Mar 2018,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,667,969 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, CHURCHILL MANAGEMENT Corp, Navellier & Associates Inc, ROYAL BANK OF CANADA, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, and AMERIPRISE FINANCIAL INC.
This page lists
152
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.